Catherine M. Wiscount

Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors

Terry A. Lyle, Catherine M. Wiscount, James P. Guare et al. · Journal of Medicinal Chemistry · 1991 · 97 citations · Full text

Hiv Protease Inhibitors, Altmetric Attention Score, Pharmacotherapy +17

Synthesis of a Series of 4-(Arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

Thomas J. Tucker, Terry A. Lyle, Catherine M. Wiscount et al. · Journal of Medicinal Chemistry · 1994 · 70 citations · Full text

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors

Christopher J. Bungard, Peter Williams, Jürgen Schulz et al. · ACS Medicinal Chemistry Letters · 2017 · 43 citations · Full text

Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability

Donnette D. Staas, Kelly L. Savage, Vanessa Sherman et al. · Bioorganic & Medicinal Chemistry · 2006 · 37 citations

Chemical Biology, Thrombosis, Medicinal Chemistry +12

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group

Christopher J. Bungard, Peter Williams, Jeanine Ballard et al. · ACS Medicinal Chemistry Letters · 2016 · 28 citations · Full text

Crystal Structure, Medicinal Chemistry, Biochemistry +15